Search
Paul Anderson says the share price trend did not reflect progress behind the scenes.

Orthocell soars 356% on test results

Shares in Perth biotech Orthocell more than quadrupled in value today after the company released positive results from a trial of its nerve regeneration product.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Orthocell (OCC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Source: Morningstar

Total Shareholder Return as at 30/04/19

1 year TSR5 year TSR
thWide Open Agriculture
271stVDM Group0%-22%
614thIntiger Group-50%15%
709thOrthocell-63%
717thTV2U International-65%-30%
729 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/05/18
$17k Issued
09/05/18
$20k Issued
09/05/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

140th↑Orthocell$884k
145th↑TV2U International$640k
146th↑Intiger Group$640k
148th↓VDM Group$561k
149th↑Wide Open Agriculture$552k
199 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer